コンテンツへスキップ
Merck
  • Sensitization of sodium appetite: evidence for sustained molecular changes in the lamina terminalis.

Sensitization of sodium appetite: evidence for sustained molecular changes in the lamina terminalis.

American journal of physiology. Regulatory, integrative and comparative physiology (2014-10-31)
Seth W Hurley, Zhongming Zhang, Terry G Beltz, Baojian Xue, Alan Kim Johnson
要旨

Animals with a history of sodium depletions exhibit increases in salt intake, a phenomenon described as the sensitization of sodium appetite. Using a novel experimental design, the present experiments investigated whether putative molecular markers of neural plasticity and changes in the message for components of the brain renin-angiotensin-aldosterone-system (RAAS) accompany the sensitization of sodium appetite. An initial set of experiments examined whether the glutamatergic N-methyl-d-aspartate receptor antagonist MK-801 would attenuate sodium appetite sensitization and prevent changes in mRNA expression associated with sensitization. Rats with repeated sodium depletions exhibited enhanced sodium appetite and mRNA expression for components of the RAAS in areas along the lamina terminalis (LT), a region of the brain that is important for the regulation of body fluid homeostasis, and these effects were significantly attenuated by MK-801 pretreatment. A second set of experiments investigated whether successive sodium depletions would elevate sodium intake and induce a pattern of fos-B staining consistent with the Δfos-B isoform in areas along the LT. The pattern of fos-B staining in the subfornical organ was consistent with the characteristics of Δfos-B expression. Specifically, fos-B/Δfos-B expression was increased 4 days after the last of a series of sodium depletions, fos-B/Δfos-B expression was nearly absent in control rats, and the quantity of fos-B/Δfos-B staining was directly associated with a history of sodium depletions. These findings demonstrate that the sensitization of sodium appetite is associated with sustained molecular alterations in the LT that are indicative of neural plasticity and upregulation of the central RAAS.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(+)-MK-801 マレイン酸水素塩, powder
Sigma-Aldrich
フロセミド
Sigma-Aldrich
カプトプリル, ≥98% (HPLC), powder
USP
フロセミド, United States Pharmacopeia (USP) Reference Standard
Supelco
フロセミド, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Furosemide solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
USP
カプトプリル, United States Pharmacopeia (USP) Reference Standard
Supelco
カプトプリル, Pharmaceutical Secondary Standard; Certified Reference Material
フロセミド, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
カプトプリル, meets USP testing specifications
カプトプリル, European Pharmacopoeia (EP) Reference Standard
フロセミド, European Pharmacopoeia (EP) Reference Standard
システム適合性用カプトプリル, European Pharmacopoeia (EP) Reference Standard